Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 488 | 346 | 609 | 779 | 1,007 |
| Operating Income | -488 | -346 | -609 | -779 | -1,007 |
| Interest Expense | 24 | 20 | 21 | 28 | 38 |
| Other Income | -240 | -27 | -32 | 233 | -125 |
| Pre-tax Income | -752 | -392 | -662 | -574 | -1,169 |
| Net Income Continuous | -752 | -392 | -662 | -574 | -1,169 |
| Minority Interests | N/A | 0 | 0 | -13 | -22 |
| Net Income | $-752 | $-392 | $-662 | $-561 | $-1,147 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.01 | 0.00 | 0.00 | N/A | N/A |
| EBITDA(a) | $137 | $-320 | $-578 | $-777 | $-1,003 |